FRIDAY, Nov. 15, 2024 -- Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most...
Vous n'êtes pas connecté
MONDAY, Nov. 18, 2024 -- For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study published online Nov. 13 in...
FRIDAY, Nov. 15, 2024 -- Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most...
FRIDAY, Nov. 15, 2024 -- Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most...
WEDNESDAY, Nov. 13, 2024 -- A deep learning model can predict the risk for obesity for young children using only routinely collected electronic health...
THURSDAY, Nov. 7, 2024 -- Sugar restriction during the first 1,000 days after conception lowers a child's risk for later developing type 2 diabetes...
Scientists from Yale and other institutions have discovered that tirzepatide, a drug approved to treat type 2 diabetes, may also be highly effective...
MONDAY, Nov. 18, 2024 -- Patients with venous thromboembolism (VTE) initiating oral anticoagulants have an increased risk for bleeding when using...
MONDAY, Nov. 18, 2024 -- For children with achondroplasia, oral infigratinib does not result in major safety signals and yields increased annualized...
WEDNESDAY, Nov. 6, 2024 -- For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (T-TEER)...
THURSDAY, Nov. 7, 2024 -- Greater hospital COVID-19 burden is associated with an increased risk for in-hospital adverse events (AEs) among patients...
MONDAY, Nov. 18, 2024 -- Gabapentinoid use is associated with an increased risk for hip fractures, according to a study published online Nov. 13 in...